Operating in the future tense: management treats the next, larger stage of the business as already underway, and the fir
The model's full reasoning — Q4 2022 call → NOWe need to determine if management discusses a larger next stage that they are already operating toward, and whether the first stage is already real with concrete current activity. The question asks for a specific trajectory: present producing and bigger next stage as working assumption. Looking at the transcript, there are several potential trajectories. For example, aflibercept 8 mg: they have submitted BLA, expect launch late August. But that's not yet launched, so first stage not real. Dupixent: ongoing growth, but that's steady growth. Oncology: they have data, but many are in trials. The costim bispecifics: they have early data, but still in trials. The COVID antibody: not yet in clinic. The most promising might be the Libtayo expansion: they have approval and are launching, with plans to expand. But is there a "larger next stage" they are operating toward? They mention expanding into more indications and geographies, but that's typical growth. Another: odronextamab and linvoseltamab: they plan regulatory submissions in second half, but not yet approved. So first stage not real. The question asks: "On this call, does management talk about a LARGER NEXT STAGE of the company's business as something it is ALREADY OPERATING TOWARD — planning, preparing, scheduling, staffing, producing, or making decisions on the working assumption that this bigger stage is coming — AND is the FIRST STAGE of that same trajectory ALREADY REAL today, with management pointing to concrete current activity (actual orders, customers, shipments, deployments, work, output, or usage happening now) that the larger stage grows directly out of?" We need to find a specific example where they have current real activity and they are planning a larger continuation. For instance, they mention "we are preparing for a potential U.S. launch for aflibercept 8 milligrams in late August" but that's not yet launched. They have EYLEA currently, but that's a different product. The trajectory might be from EYLEA to aflibercept 8 mg, but EYLEA is already established, and the 8 mg is a new product, not a larger stage of the same activity? Actually, it's a continuation of the retinal franchise. But the first stage (EYLEA) is real, and the larger stage (8 mg) is coming. However, is management "operating toward" it? They are preparing for launch, but it's conditional on approval. They say "potential U.S.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| GPRO | GoPro, Inc. | Q4 2023 | 2024-02-07 | F |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| UAL | United Airlines Holdings, Inc. | Q4 2022 | 2023-01-18 | B |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| PKX | POSCO Holdings Inc. | Q3 2022 | 2022-10-24 | D |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| SQM | Sociedad Química y Minera de Chile S.A. | Q1 2022 | 2022-05-19 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| ZENV | Zenvia Inc. | Q4 2021 | 2022-03-17 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| AKAM | Akamai Technologies, Inc. | Q4 2021 | 2022-02-15 | B |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
XOM · Q2 2018 → YESThe question is about whether management talks about a larger next stage of the business that they're already operating toward, and if the first stage is already real with concrete current activity. ...YES The transcript shows management treating Guyana as the larger next stage of their Upstream growth trajectory. They describe concrete current activity in exploration and early development (eighth discovery on Stabroek block, Longtail well with 256 feet of high-quality oil, pre-drilling at Liza-1 Phase 1 starting May 2018 with Noble Bob Douglas rig, top hole sections on six wells completed, intermediate sections underway, conversion work on FPSO Liza Destiny progressing in Singapore, draft environmental impact assessment and development plan submitted for Liza Phase 2 targeting 2022 start-up, Payara development targeting FID 2019 with 180 kbpd 2022-2023) as the validated beginning of a program that will deliver up to 5 FPSOs producing over 750,000 barrels per day by 2025 from current zero production.
NC · Q1 2024 → YESThe question is about whether management talks about a larger next stage of the business that they're already operating toward, and if the first stage is already real with concrete current activity. ...YES The transcript shows management treating Mitigation Resources as the larger next stage of the company's business, already operating toward it with concrete current activity in advancing existing projects and acquiring new land (first stage now producing modest income trajectory), while planning, resourcing, and sequencing for further expansion with sustainable profitability in future years as the working 2025+ assumption. North American Mining's lithium contract similarly qualifies as the first stage (Sawtooth contributing moderate income now during construction) growing directly into the production phase (2027-2028) as the larger stage, with the company sequencing toward it under the contract.
EMKR · Q4 2023 → YESThe question is about whether management talks about a larger next stage of the business that they're already operating toward, and if the first stage is already real with concrete current activity. ...YES The transcript shows management treating the current Inertial Navigation business as the validated first stage of a larger aerospace and defense trajectory. They point to concrete present activity: $26.8 million Q4 revenue (sixth consecutive quarter of sequential growth), $67 million backlog, first low-rate initial production shipments of an advanced targeting system expected this quarter (pending circuit boards), doubling production for the Mark 48 torpedo (already notified by Navy), additional production orders for precision guided munitions, and Ukraine business expansion. These are not pipeline items; they are shipments, production ramps, and orders already in motion.